U S Stem Cell (USRM) Stock Price, News & Analysis
Company Description
U S Stem Cell (OTC Link: USRM) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $64.2K.
USRM has gained 0.0% over the past month. Shares last traded at $0.0001.
For FY2022, U S Stem Cell reported revenue of $82K.
This page collects what Stock Titan holds for USRM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
U S Stem Cell (USRM) stock last closed at $0.0001. Over the past month, the stock has gained 0.0%. At a market capitalization of $64.2K, USRM is classified as a micro-cap stock with approximately 641.5M shares outstanding.
Latest News
U S Stem Cell has 6 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. View all USRM news →
SEC Filings
Financial Highlights
U S Stem Cell generated $82K in revenue in FY2022, retaining a 71.0% gross margin. The company generated -$305K in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
USRM Company Profile & Sector Positioning
U S Stem Cell (USRM) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing USRM often look at related companies in the same sector, including Syros Pharmaceut (SYRS), Aridis Pharmaceuticals Inc (ARDS), Adhera Therapeutics Inc (ATRX), GB Sciences (GBLX), and Navidea Biopharm (NAVB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate USRM's relative position within its industry.